

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.74560420 |
| 2 | drug catabolic process (GO:0042737) | 9.74522282 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.65311297 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.65311297 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.30356283 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.30356283 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 7.06822700 |
| 8 | drug metabolic process (GO:0017144) | 6.62567432 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.57185720 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.57185720 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.57185720 |
| 12 | oxidative demethylation (GO:0070989) | 6.40429597 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.37513538 |
| 14 | bile acid biosynthetic process (GO:0006699) | 6.35295569 |
| 15 | tryptophan metabolic process (GO:0006568) | 6.14024897 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.98006563 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.95660065 |
| 18 | urea cycle (GO:0000050) | 5.83565361 |
| 19 | urea metabolic process (GO:0019627) | 5.83565361 |
| 20 | * regulation of protein activation cascade (GO:2000257) | 5.72347281 |
| 21 | acute-phase response (GO:0006953) | 5.69263803 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.64843801 |
| 23 | * complement activation, alternative pathway (GO:0006957) | 5.55376294 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.52860557 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.51490362 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.46007291 |
| 27 | protein carboxylation (GO:0018214) | 5.46007291 |
| 28 | ethanol metabolic process (GO:0006067) | 5.44863050 |
| 29 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.43811944 |
| 30 | cysteine metabolic process (GO:0006534) | 5.41988608 |
| 31 | * regulation of complement activation (GO:0030449) | 5.37584201 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.36384654 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 5.35146954 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 5.27303861 |
| 35 | bile acid metabolic process (GO:0008206) | 5.25039532 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.24882554 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.11658102 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.11645461 |
| 39 | * regulation of humoral immune response (GO:0002920) | 5.11149586 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 5.10963734 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.93153528 |
| 42 | phenylpropanoid metabolic process (GO:0009698) | 4.88905019 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.87275479 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.80213498 |
| 45 | S-adenosylmethionine metabolic process (GO:0046500) | 4.77374186 |
| 46 | lysine metabolic process (GO:0006553) | 4.72540713 |
| 47 | lysine catabolic process (GO:0006554) | 4.72540713 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.69762677 |
| 49 | coenzyme catabolic process (GO:0009109) | 4.69632122 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 4.63103351 |
| 51 | reverse cholesterol transport (GO:0043691) | 4.62064150 |
| 52 | negative regulation of blood coagulation (GO:0030195) | 4.61151524 |
| 53 | negative regulation of hemostasis (GO:1900047) | 4.61151524 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.60688463 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.60688463 |
| 56 | macromolecular complex remodeling (GO:0034367) | 4.56376866 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56376866 |
| 58 | protein-lipid complex remodeling (GO:0034368) | 4.56376866 |
| 59 | amine catabolic process (GO:0009310) | 4.53621763 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.53621763 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.52277036 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.52249964 |
| 63 | glycine metabolic process (GO:0006544) | 4.51529585 |
| 64 | regulation of cholesterol esterification (GO:0010872) | 4.47848371 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.38764536 |
| 66 | cellular glucuronidation (GO:0052695) | 4.33094568 |
| 67 | phospholipid efflux (GO:0033700) | 4.32641691 |
| 68 | negative regulation of sterol transport (GO:0032372) | 4.31730938 |
| 69 | negative regulation of cholesterol transport (GO:0032375) | 4.31730938 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.31234823 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 4.27086678 |
| 72 | ethanol oxidation (GO:0006069) | 4.27004814 |
| 73 | glutamate metabolic process (GO:0006536) | 4.26673296 |
| 74 | cellular ketone body metabolic process (GO:0046950) | 4.20108721 |
| 75 | negative regulation of wound healing (GO:0061045) | 4.19541116 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 4.18707650 |
| 77 | negative regulation of coagulation (GO:0050819) | 4.18545854 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.18346607 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.15721502 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.10012320 |
| 81 | acute inflammatory response (GO:0002526) | 4.09855295 |
| 82 | negative regulation of complement activation (GO:0045916) | 4.09623325 |
| 83 | fibrinolysis (GO:0042730) | 4.09218334 |
| 84 | cholesterol efflux (GO:0033344) | 4.06525447 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 4.04257140 |
| 86 | arginine metabolic process (GO:0006525) | 4.03583428 |
| 87 | * cytolysis (GO:0019835) | 4.02369929 |
| 88 | aldehyde catabolic process (GO:0046185) | 4.02170830 |
| 89 | * complement activation, classical pathway (GO:0006958) | 4.00402175 |
| 90 | positive regulation of blood coagulation (GO:0030194) | 3.95688013 |
| 91 | positive regulation of hemostasis (GO:1900048) | 3.95688013 |
| 92 | hormone catabolic process (GO:0042447) | 3.95201776 |
| 93 | alkaloid metabolic process (GO:0009820) | 3.94681990 |
| 94 | * complement activation (GO:0006956) | 3.93751147 |
| 95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.92432042 |
| 96 | flavonoid metabolic process (GO:0009812) | 3.92017642 |
| 97 | cofactor catabolic process (GO:0051187) | 3.89932481 |
| 98 | acetyl-CoA metabolic process (GO:0006084) | 3.88399925 |
| 99 | * protein activation cascade (GO:0072376) | 3.86981360 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.84545925 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.84545925 |
| 102 | plasma lipoprotein particle assembly (GO:0034377) | 3.79769027 |
| 103 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79260499 |
| 104 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76451302 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.72802109 |
| 106 | organic acid catabolic process (GO:0016054) | 3.72802109 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.71668299 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.70212321 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.70212321 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70135105 |
| 111 | regulation of apoptotic cell clearance (GO:2000425) | 3.68861098 |
| 112 | response to mercury ion (GO:0046689) | 3.68341515 |
| 113 | cholesterol homeostasis (GO:0042632) | 3.68204394 |
| 114 | regulation of cholesterol homeostasis (GO:2000188) | 3.66828781 |
| 115 | NAD biosynthetic process (GO:0009435) | 3.64969432 |
| 116 | ketone body metabolic process (GO:1902224) | 3.63459412 |
| 117 | positive regulation of coagulation (GO:0050820) | 3.62469320 |
| 118 | sterol homeostasis (GO:0055092) | 3.62121222 |
| 119 | positive regulation of lipid catabolic process (GO:0050996) | 3.62045459 |
| 120 | opsonization (GO:0008228) | 3.60843356 |
| 121 | * killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.59659964 |
| 122 | * disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.59659964 |
| 123 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59118838 |
| 124 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59118838 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.58661175 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 3.57986409 |
| 127 | heme transport (GO:0015886) | 3.56664363 |
| 128 | * regulation of acute inflammatory response (GO:0002673) | 3.54506229 |
| 129 | sodium-independent organic anion transport (GO:0043252) | 3.51433110 |
| 130 | xenobiotic metabolic process (GO:0006805) | 3.50380780 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.47833251 |
| 132 | intestinal cholesterol absorption (GO:0030299) | 3.42364497 |
| 133 | oxaloacetate metabolic process (GO:0006107) | 3.41868673 |
| 134 | exogenous drug catabolic process (GO:0042738) | 10.4352115 |
| 135 | omega-hydroxylase P450 pathway (GO:0097267) | 10.1720530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34901900 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.23375108 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20824359 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48649379 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.34601552 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.98864026 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.66398213 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.16109478 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.87340478 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.84119857 |
| 11 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03572645 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9882663 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95026135 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93672497 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61680596 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60388045 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60387415 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52416502 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.48538546 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41079376 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29242588 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26701168 |
| 23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21728203 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21252157 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16685220 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02638945 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00211593 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98770762 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95344245 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93550670 |
| 31 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.91695611 |
| 32 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90096086 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87644681 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87015524 |
| 35 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.85797077 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84154920 |
| 37 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81532623 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79885935 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79272917 |
| 40 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79108060 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79061747 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78638025 |
| 43 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78424688 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77974869 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.77553749 |
| 46 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76865469 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76594709 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76357575 |
| 49 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76326453 |
| 50 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76189672 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75237615 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.73971213 |
| 53 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73322945 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73264147 |
| 55 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73231803 |
| 56 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73231394 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71435201 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71435201 |
| 59 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71275620 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70999799 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70360588 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67617012 |
| 63 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66432275 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64617897 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64536984 |
| 66 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64236908 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.62834737 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.62145828 |
| 69 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.61944269 |
| 70 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.61596901 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.61175540 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60700759 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59289779 |
| 74 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.58233186 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56979003 |
| 76 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.56907188 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55256497 |
| 78 | NFYB_21822215_ChIP-Seq_K562_Human | 0.55177100 |
| 79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55131133 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55107608 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.55070094 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.55048600 |
| 83 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54750305 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.54697341 |
| 85 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54144877 |
| 86 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53579579 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.53514944 |
| 88 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53322406 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.53069531 |
| 90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52898842 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.52332168 |
| 92 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.52151926 |
| 93 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.52092911 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51730686 |
| 95 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.51579651 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.50992540 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50437791 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50399368 |
| 99 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50069526 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.49660914 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49328519 |
| 102 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49317348 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48171743 |
| 104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.47518690 |
| 105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.47496523 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46353677 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46140159 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45766372 |
| 109 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.45699730 |
| 110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45027425 |
| 111 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.44892051 |
| 112 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.44836020 |
| 113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44387494 |
| 114 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.44370289 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44001400 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43132507 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42878577 |
| 118 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42715914 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42325625 |
| 120 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39896609 |
| 121 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39552687 |
| 122 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38613206 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38441519 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37785926 |
| 125 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37705922 |
| 126 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37355507 |
| 127 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36790159 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.36512841 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36470536 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.35998230 |
| 131 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35977821 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.35950384 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35871801 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.35599048 |
| 135 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.35496889 |
| 136 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35046035 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.34991344 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.34591713 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.34224117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.26293084 |
| 2 | MP0005360_urolithiasis | 7.65191890 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.63770545 |
| 4 | MP0005365_abnormal_bile_salt | 6.24048742 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.85617831 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.38443111 |
| 7 | MP0003252_abnormal_bile_duct | 4.05711283 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.53466332 |
| 9 | MP0009840_abnormal_foam_cell | 3.05273536 |
| 10 | MP0005083_abnormal_biliary_tract | 2.95161419 |
| 11 | MP0003195_calcinosis | 2.75451024 |
| 12 | MP0005332_abnormal_amino_acid | 2.70953680 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.64930030 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.25293884 |
| 15 | MP0000609_abnormal_liver_physiology | 2.15778964 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.07593980 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.06346657 |
| 18 | MP0003868_abnormal_feces_composition | 2.05238212 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.99768077 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84674687 |
| 21 | MP0001764_abnormal_homeostasis | 1.66383681 |
| 22 | MP0009697_abnormal_copulation | 1.64960673 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54973716 |
| 24 | MP0003011_delayed_dark_adaptation | 1.39359161 |
| 25 | MP0005647_abnormal_sex_gland | 1.25533028 |
| 26 | MP0003186_abnormal_redox_activity | 1.24093218 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.20786812 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.20051418 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.19781148 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17510511 |
| 31 | MP0005451_abnormal_body_composition | 1.13342093 |
| 32 | MP0009764_decreased_sensitivity_to | 1.06132815 |
| 33 | MP0002254_reproductive_system_inflammat | 1.03757238 |
| 34 | MP0009763_increased_sensitivity_to | 1.02570918 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.00802459 |
| 36 | MP0000604_amyloidosis | 0.98964108 |
| 37 | MP0002282_abnormal_trachea_morphology | 0.96291579 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.92080742 |
| 39 | MP0008469_abnormal_protein_level | 0.91379958 |
| 40 | MP0005408_hypopigmentation | 0.85534169 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.85471153 |
| 42 | MP0005670_abnormal_white_adipose | 0.83557023 |
| 43 | MP0001915_intracranial_hemorrhage | 0.80754709 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 0.80471418 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.79766549 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.79588022 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.79236237 |
| 48 | MP0002876_abnormal_thyroid_physiology | 0.77014486 |
| 49 | MP0005187_abnormal_penis_morphology | 0.76903960 |
| 50 | MP0009765_abnormal_xenobiotic_induced | 0.76524822 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.74131803 |
| 52 | MP0002249_abnormal_larynx_morphology | 0.72731086 |
| 53 | MP0004381_abnormal_hair_follicle | 0.71784984 |
| 54 | MP0004130_abnormal_muscle_cell | 0.70907731 |
| 55 | MP0005535_abnormal_body_temperature | 0.69654746 |
| 56 | MP0002971_abnormal_brown_adipose | 0.68002892 |
| 57 | MP0005023_abnormal_wound_healing | 0.67057308 |
| 58 | MP0005334_abnormal_fat_pad | 0.67006763 |
| 59 | MP0005266_abnormal_metabolism | 0.66814702 |
| 60 | MP0003690_abnormal_glial_cell | 0.66395647 |
| 61 | MP0009053_abnormal_anal_canal | 0.63420107 |
| 62 | MP0009785_altered_susceptibility_to | 0.62486645 |
| 63 | MP0001661_extended_life_span | 0.60271874 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.57731340 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.57613942 |
| 66 | MP0009384_cardiac_valve_regurgitation | 0.56017754 |
| 67 | MP0003329_amyloid_beta_deposits | 0.54630797 |
| 68 | MP0003879_abnormal_hair_cell | 0.54187085 |
| 69 | MP0000579_abnormal_nail_morphology | 0.52559964 |
| 70 | MP0009379_abnormal_foot_pigmentation | 0.51335266 |
| 71 | MP0001756_abnormal_urination | 0.51334122 |
| 72 | MP0002928_abnormal_bile_duct | 0.51056433 |
| 73 | MP0005448_abnormal_energy_balance | 0.49942802 |
| 74 | MP0003724_increased_susceptibility_to | 0.47621775 |
| 75 | MP0005166_decreased_susceptibility_to | 0.47567880 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.47353371 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.46936755 |
| 78 | MP0005395_other_phenotype | 0.46289862 |
| 79 | MP0003718_maternal_effect | 0.45042462 |
| 80 | MP0002822_catalepsy | 0.43829302 |
| 81 | MP0008873_increased_physiological_sensi | 0.42914655 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.42158602 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.41208779 |
| 84 | MP0008874_decreased_physiological_sensi | 0.41172127 |
| 85 | MP0002796_impaired_skin_barrier | 0.41009494 |
| 86 | MP0003436_decreased_susceptibility_to | 0.40555130 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.39613523 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.39613523 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.39220926 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.39162288 |
| 91 | MP0003075_altered_response_to | 0.39029646 |
| 92 | MP0000467_abnormal_esophagus_morphology | 0.38019591 |
| 93 | MP0005248_abnormal_Harderian_gland | 0.37715538 |
| 94 | MP0003953_abnormal_hormone_level | 0.37266101 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.36903710 |
| 96 | MP0005164_abnormal_response_to | 0.35233469 |
| 97 | MP0009672_abnormal_birth_weight | 0.34900501 |
| 98 | MP0001881_abnormal_mammary_gland | 0.32013668 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.31610780 |
| 100 | MP0000427_abnormal_hair_cycle | 0.31398911 |
| 101 | MP0004883_abnormal_blood_vessel | 0.31036070 |
| 102 | MP0001851_eye_inflammation | 0.30395827 |
| 103 | MP0009115_abnormal_fat_cell | 0.29989829 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.29464963 |
| 105 | MP0006082_CNS_inflammation | 0.28905887 |
| 106 | MP0002970_abnormal_white_adipose | 0.28844679 |
| 107 | MP0002060_abnormal_skin_morphology | 0.28756267 |
| 108 | MP0008872_abnormal_physiological_respon | 0.28698195 |
| 109 | MP0001853_heart_inflammation | 0.28144203 |
| 110 | MP0000249_abnormal_blood_vessel | 0.27695382 |
| 111 | MP0000566_synostosis | 0.27415878 |
| 112 | MP0002132_abnormal_respiratory_system | 0.27387511 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.27174681 |
| 114 | MP0001243_abnormal_dermal_layer | 0.27097748 |
| 115 | MP0002128_abnormal_blood_circulation | 0.27085006 |
| 116 | MP0002168_other_aberrant_phenotype | 0.27000437 |
| 117 | MP0003633_abnormal_nervous_system | 0.20284237 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.16568282 |
| 119 | MP0002135_abnormal_kidney_morphology | 0.16511298 |
| 120 | MP0005595_abnormal_vascular_smooth | 0.16192173 |
| 121 | MP0005197_abnormal_uvea_morphology | 0.15302471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.74320474 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.43898489 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.32973997 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.74322711 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.73049959 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.35597546 |
| 7 | Xanthomatosis (HP:0000991) | 6.29318695 |
| 8 | * Complement deficiency (HP:0004431) | 5.85419944 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.39787501 |
| 10 | Joint hemorrhage (HP:0005261) | 4.80787005 |
| 11 | Epidermoid cyst (HP:0200040) | 4.71090076 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.70215862 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.60284786 |
| 14 | Hyperammonemia (HP:0001987) | 4.54624236 |
| 15 | Hyperglycinemia (HP:0002154) | 4.49950739 |
| 16 | Fat malabsorption (HP:0002630) | 4.42748306 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.30224040 |
| 18 | Nephritis (HP:0000123) | 4.21876783 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20142392 |
| 20 | Ketosis (HP:0001946) | 4.18066032 |
| 21 | * Abnormality of complement system (HP:0005339) | 4.16180059 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.15804460 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07988587 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.04093257 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.03927477 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.93157343 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86044562 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.84037780 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84037780 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80890513 |
| 31 | Hyperglycinuria (HP:0003108) | 3.80422379 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.78871739 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.47464067 |
| 34 | Steatorrhea (HP:0002570) | 3.40997522 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34397815 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.25904969 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23719315 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 3.19455572 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.15050847 |
| 40 | Spontaneous abortion (HP:0005268) | 3.13995248 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.09668750 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.08306487 |
| 43 | Myocardial infarction (HP:0001658) | 3.04536899 |
| 44 | Delayed CNS myelination (HP:0002188) | 3.02867580 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 3.00648836 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00640964 |
| 47 | Ketoacidosis (HP:0001993) | 2.94004366 |
| 48 | Skin nodule (HP:0200036) | 2.91332894 |
| 49 | Neonatal hypoglycemia (HP:0001998) | 2.83922958 |
| 50 | Osteomalacia (HP:0002749) | 2.67107912 |
| 51 | Metabolic acidosis (HP:0001942) | 2.64387925 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.60516190 |
| 53 | Acanthocytosis (HP:0001927) | 2.60463986 |
| 54 | Lethargy (HP:0001254) | 2.55243495 |
| 55 | Fair hair (HP:0002286) | 2.51895854 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.50697996 |
| 57 | Spastic diplegia (HP:0001264) | 2.48478601 |
| 58 | Neonatal onset (HP:0003623) | 2.47686406 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.47661478 |
| 60 | Gout (HP:0001997) | 2.45304452 |
| 61 | Cholelithiasis (HP:0001081) | 2.44882687 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43879247 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.43879247 |
| 64 | Vascular calcification (HP:0004934) | 2.43791529 |
| 65 | Cholecystitis (HP:0001082) | 2.43418316 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.43418316 |
| 67 | Mitral stenosis (HP:0001718) | 2.43366937 |
| 68 | Purpura (HP:0000979) | 2.39636624 |
| 69 | Cerebral edema (HP:0002181) | 2.38377472 |
| 70 | Glomerulonephritis (HP:0000099) | 2.36004438 |
| 71 | Irritability (HP:0000737) | 2.31740363 |
| 72 | Pulmonary embolism (HP:0002204) | 2.30810906 |
| 73 | Joint swelling (HP:0001386) | 2.27213762 |
| 74 | Sensorimotor neuropathy (HP:0007141) | 2.26629564 |
| 75 | Gingival bleeding (HP:0000225) | 2.25834902 |
| 76 | Amyloidosis (HP:0011034) | 2.23831008 |
| 77 | Esophageal varix (HP:0002040) | 2.18551506 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.15909875 |
| 79 | Pancreatitis (HP:0001733) | 2.14359944 |
| 80 | Malnutrition (HP:0004395) | 2.13035907 |
| 81 | Enlarged kidneys (HP:0000105) | 2.09426019 |
| 82 | Thrombophlebitis (HP:0004418) | 2.08964894 |
| 83 | Late onset (HP:0003584) | 2.06526040 |
| 84 | Abnormality of the gallbladder (HP:0005264) | 2.06388706 |
| 85 | Menorrhagia (HP:0000132) | 2.06237387 |
| 86 | Brushfield spots (HP:0001088) | 2.05940991 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02687049 |
| 88 | Opisthotonus (HP:0002179) | 2.01704995 |
| 89 | Vomiting (HP:0002013) | 1.99527050 |
| 90 | Hemorrhage of the eye (HP:0011885) | 1.96156344 |
| 91 | Poikilocytosis (HP:0004447) | 1.94682736 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 1.94082446 |
| 93 | Increased serum ferritin (HP:0003281) | 1.92800281 |
| 94 | Rickets (HP:0002748) | 1.92756229 |
| 95 | Epistaxis (HP:0000421) | 1.92427519 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.91961484 |
| 97 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91560920 |
| 98 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91173993 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.90425453 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88910221 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.88073652 |
| 102 | Abnormal delivery (HP:0001787) | 1.87982162 |
| 103 | Hyperphosphaturia (HP:0003109) | 1.85106478 |
| 104 | Status epilepticus (HP:0002133) | 1.83018764 |
| 105 | Elevated hepatic transaminases (HP:0002910) | 1.82394696 |
| 106 | Hypophosphatemic rickets (HP:0004912) | 1.81684481 |
| 107 | Renal cortical cysts (HP:0000803) | 1.81121191 |
| 108 | Hyperglycemia (HP:0003074) | 1.80642413 |
| 109 | Cerebral palsy (HP:0100021) | 1.77958289 |
| 110 | Generalized hypopigmentation of hair (HP:0011358) | 1.77439599 |
| 111 | Abnormality of vitamin metabolism (HP:0100508) | 1.75086050 |
| 112 | Elevated alkaline phosphatase (HP:0003155) | 1.73389673 |
| 113 | Alkalosis (HP:0001948) | 1.70682478 |
| 114 | Arthropathy (HP:0003040) | 1.69842257 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.69411735 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.69411735 |
| 117 | Gangrene (HP:0100758) | 1.68224278 |
| 118 | Increased mean platelet volume (HP:0011877) | 1.64571960 |
| 119 | Glycosuria (HP:0003076) | 1.64261700 |
| 120 | Abnormality of urine glucose concentration (HP:0011016) | 1.64261700 |
| 121 | Increased serum pyruvate (HP:0003542) | 1.60593887 |
| 122 | Bile duct proliferation (HP:0001408) | 1.58243676 |
| 123 | Abnormal biliary tract physiology (HP:0012439) | 1.58243676 |
| 124 | Blue irides (HP:0000635) | 1.58056961 |
| 125 | Atrioventricular block (HP:0001678) | 1.55444318 |
| 126 | Abnormality of the Achilles tendon (HP:0005109) | 1.49189782 |
| 127 | Abnormal platelet volume (HP:0011876) | 1.49142378 |
| 128 | Abnormal platelet function (HP:0011869) | 1.47565319 |
| 129 | Impaired platelet aggregation (HP:0003540) | 1.47565319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.78158162 |
| 2 | ERN1 | 4.71408518 |
| 3 | FGFR4 | 4.64634489 |
| 4 | SIK1 | 4.18263516 |
| 5 | ERBB4 | 3.88701916 |
| 6 | TAOK3 | 3.26921034 |
| 7 | INSRR | 3.07794225 |
| 8 | MAP2K4 | 2.39796741 |
| 9 | MAPK11 | 2.22323685 |
| 10 | MST1R | 2.12294373 |
| 11 | LATS1 | 1.87801720 |
| 12 | NLK | 1.82613964 |
| 13 | PIK3CG | 1.77294791 |
| 14 | PRPF4B | 1.75885658 |
| 15 | PKN2 | 1.69809455 |
| 16 | TYK2 | 1.66327329 |
| 17 | FLT3 | 1.60809237 |
| 18 | TRIB3 | 1.56753487 |
| 19 | TNK2 | 1.54747145 |
| 20 | NEK9 | 1.54229047 |
| 21 | FER | 1.51625207 |
| 22 | ABL2 | 1.50507311 |
| 23 | FGFR2 | 1.47050275 |
| 24 | FRK | 1.46957631 |
| 25 | NTRK3 | 1.46115461 |
| 26 | PTK6 | 1.41666613 |
| 27 | DAPK2 | 1.37299859 |
| 28 | JAK2 | 1.34243301 |
| 29 | MAP3K7 | 1.31538043 |
| 30 | CAMKK2 | 1.29923416 |
| 31 | ERBB2 | 1.28830447 |
| 32 | KDR | 1.14876894 |
| 33 | JAK1 | 1.11505938 |
| 34 | PRKAA2 | 1.08952123 |
| 35 | BLK | 1.07090793 |
| 36 | PINK1 | 1.04244054 |
| 37 | GRK6 | 1.03504370 |
| 38 | TBK1 | 1.03342802 |
| 39 | MAP3K14 | 1.00573011 |
| 40 | MAP3K10 | 0.99232060 |
| 41 | MAPK4 | 0.98622570 |
| 42 | MAPK15 | 0.96635206 |
| 43 | MAP2K3 | 0.93709919 |
| 44 | PRKG1 | 0.93512788 |
| 45 | PKN1 | 0.92331013 |
| 46 | STK38L | 0.92295161 |
| 47 | PRKCZ | 0.90674749 |
| 48 | EPHA3 | 0.88698840 |
| 49 | CAMK2G | 0.88444083 |
| 50 | MET | 0.85778343 |
| 51 | EPHB1 | 0.83858221 |
| 52 | MAP3K3 | 0.80225994 |
| 53 | SCYL2 | 0.80002558 |
| 54 | MAP3K2 | 0.79828557 |
| 55 | CDK6 | 0.79140176 |
| 56 | PRKACA | 0.78562367 |
| 57 | BRSK2 | 0.77834246 |
| 58 | MAPK12 | 0.77692007 |
| 59 | AKT3 | 0.76723460 |
| 60 | PRKACG | 0.73974633 |
| 61 | MYLK | 0.69939185 |
| 62 | PDK2 | 0.69867549 |
| 63 | CAMKK1 | 0.69567392 |
| 64 | IRAK3 | 0.68380065 |
| 65 | TIE1 | 0.68306234 |
| 66 | ZAP70 | 0.68120134 |
| 67 | GSK3A | 0.67265461 |
| 68 | CAMK1D | 0.67217683 |
| 69 | RIPK1 | 0.65773618 |
| 70 | MAP3K11 | 0.65273481 |
| 71 | PRKAA1 | 0.64987967 |
| 72 | FGFR3 | 0.63368412 |
| 73 | DYRK1B | 0.62728434 |
| 74 | SGK3 | 0.62640958 |
| 75 | MAP2K6 | 0.60032081 |
| 76 | PRKACB | 0.59858021 |
| 77 | KSR2 | 0.58798776 |
| 78 | MAPK7 | 0.58684821 |
| 79 | CSK | 0.57910449 |
| 80 | CSF1R | 0.54829534 |
| 81 | CSNK1E | 0.54392444 |
| 82 | PRKCB | 0.52649324 |
| 83 | IKBKE | 0.52613342 |
| 84 | RPS6KA3 | 0.50656244 |
| 85 | WNK3 | 0.50608906 |
| 86 | PTK2 | 0.49189440 |
| 87 | PRKCQ | 0.48918331 |
| 88 | CSNK1G1 | 0.47656888 |
| 89 | PDPK1 | 0.47644781 |
| 90 | TGFBR2 | 0.47473553 |
| 91 | MAP3K5 | 0.47205137 |
| 92 | SGK2 | 0.46336280 |
| 93 | IGF1R | 0.45781468 |
| 94 | CSNK1D | 0.45043065 |
| 95 | ARAF | 0.44982541 |
| 96 | EGFR | 0.43489390 |
| 97 | MAP2K1 | 0.43017833 |
| 98 | GRK1 | 0.40228448 |
| 99 | MAP3K6 | 0.40138097 |
| 100 | SRC | 0.39517718 |
| 101 | MAP3K13 | 0.39493367 |
| 102 | PRKCG | 0.39464715 |
| 103 | EPHA4 | 0.38416470 |
| 104 | RET | 0.38010823 |
| 105 | BMX | 0.37850468 |
| 106 | CDK4 | 0.37713936 |
| 107 | LATS2 | 0.37712583 |
| 108 | KIT | 0.37073582 |
| 109 | ICK | 0.36449409 |
| 110 | CAMK1G | 0.35080474 |
| 111 | CSNK2A1 | 0.34982550 |
| 112 | MTOR | 0.34972181 |
| 113 | MUSK | 0.34288260 |
| 114 | TAOK2 | 0.34061530 |
| 115 | CAMK4 | 0.31624278 |
| 116 | SGK494 | 0.31065338 |
| 117 | SGK223 | 0.31065338 |
| 118 | MAP3K1 | 0.30891164 |
| 119 | STK16 | 0.30775719 |
| 120 | IRAK1 | 0.29904146 |
| 121 | AKT2 | 0.29675541 |
| 122 | CSNK2A2 | 0.28923511 |
| 123 | MAPK3 | 0.27955003 |
| 124 | ABL1 | 0.26523251 |
| 125 | PDK1 | 0.26336936 |
| 126 | PBK | 0.26313852 |
| 127 | PIK3CA | 0.26174362 |
| 128 | CSNK1G2 | 0.25637236 |
| 129 | PRKCA | 0.25407881 |
| 130 | PAK3 | 0.25036568 |
| 131 | IRAK2 | 0.24587797 |
| 132 | PRKCH | 0.23251271 |
| 133 | CSNK1G3 | 0.22780945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.89479439 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61025900 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49549807 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20210011 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11193238 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.89203486 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73660077 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62698974 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58091507 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49537376 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44861429 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35260722 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14081604 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.11369472 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08563135 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04941808 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92104256 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88302450 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87018082 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85199312 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84897933 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82517920 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79609964 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77755529 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76789012 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73418006 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72004677 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68595144 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66280663 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64861246 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59264572 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57766304 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50977851 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50724626 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50135653 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48902056 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45133989 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33781977 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33291852 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31950200 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28871729 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28752155 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21945884 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20369691 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20073736 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16098502 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15633918 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13909049 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11520219 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10698227 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06980567 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95990134 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92530476 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91889057 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90881995 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90812222 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86088307 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.79021472 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79014412 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75896281 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68616526 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65288145 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63104626 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55399967 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53023336 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.46937073 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45997540 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45458468 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43338138 |
| 70 | * Prion diseases_Homo sapiens_hsa05020 | 0.41861051 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25890274 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24544874 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.23488293 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22702119 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22285481 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21077503 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16665659 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15739291 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11224030 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03259825 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01209798 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | -0.2645389 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2619523 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2496292 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2342007 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2301972 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2296829 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2295223 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2247387 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2196616 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | -0.2111478 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2002243 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1822803 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1765754 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1661255 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1541882 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1509267 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1490574 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1427755 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1358530 |
| 101 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1348085 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1307371 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1167929 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0985346 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0787140 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0708112 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0690586 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0663125 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.0546736 |
| 110 | * Amoebiasis_Homo sapiens_hsa05146 | -0.0121496 |

